Healthcare experiences of the Chinese patients before and during the COVID-19 pandemic: findings from a national survey study

STRENGTHS AND LIMITATIONS OF THIS STUDY

  • This study leverages a large-scale, repeated cross-sectional survey with a substantial sample size (n=62 744) conducted in 144–143 tertiary hospitals across all 31 provinces of China, enhancing the generalisability of findings within the context of China’s tertiary healthcare system.

  • By comparing patient experiences immediately before (2019) and during (2021) the COVID-19 pandemic, the study provides a unique and robust natural experiment to analyse the impact of a major public health crisis on healthcare delivery and patient perceptions.

  • Data were collected using a validated, structured questionnaire that assessed patient experiences across four key dimensions (medical process, service, environment and overall evaluation), ensuring a comprehensive and standardised measurement.

  • The sampling frame of this study comprised well-established urban tertiary hospitals, which limit the generalisability of the findings to rural populations and patients receiving care in primary healthcare settings.

  • Despite adjusting for…
    This post was originally published on https://bmjopen.bmj.com